Skip to main content
Dryad

Data for: Cross study analyses of SEND data: toxicity profile classification

Data files

May 14, 2025 version files 2.98 MB

Abstract

Large scale analysis of in vivo toxicology studies has been hindered by the lack of a standardized digital format for data analysis. The SEND standard enables the analysis of data from multiple studies performed by different laboratories. The objective of this work is to develop methods to transform, sort, and analyze data to automate cross study analysis of toxicology studies. Cross study analysis can be applied to use cases such as understanding a single compound’s toxicity profile across all studies performed and/or evaluating on- versus off-target toxicity for multiple compounds intended for the same pharmacological target. This collaborative work between BioCelerate and FDA involved development of data harmonization/transformation strategies and analytic techniques to enable cross-study analysis of both numerical and categorical SEND data. Four de-identified SEND data sets from the BioCelerate Toxicology Data Sharing module of DataCelerate® were used for the analyses. Toxicity profiles for key organ systems were developed for liver, kidney, male reproductive tract, endocrine system, and hematopoietic system using SEND domains. A Cross-Study Analysis dashboard with a built-in user-defined scoring system was created for custom cross-study analyses, including a series of radar plots enabling users to visualize and evaluate data at the organ system level and drill down into individual animal data. This data analysis provides the tools for scientists to compare toxicity profiles across multiple studies using SEND. A cross-study analysis of two different compounds intended for the same pharmacological target is described and the analyses indicate potential on-target effects to liver, kidney, and hematopoietic systems.